The atrioventricular node (AV Node) is a bundle of conduction cells that regulate the communication of atrial electrical activity with ventricular electrical activity. The AV node has a long ...
The atrioventricular node (AVN) has mystified generations of investigators over the last century and continues today to be at the epicenter of debates among anatomists, experimentalists, and ...
When high doses of AV blocking drugs are not successful to lower ventricular rates in the setting of atrial fibrillation, AV node ablation can be utilized. Remember that all atrial action potentials ...
A “pace and ablate” approach has been shown to be effective in patients with symptomatic, refractory AF. Guidelines currently ...
February 22, 2012 (Adelaide, Australia) — Atrioventricular (AV) nodal ablation significantly improves survival in heart-failure patients with atrial fibrillation (AF) who receive cardiac ...
Having an accelerated junctional rhythm occurs when the atrioventricular node in your heart beats too quickly. It happens as a result of damage to your heart’s primary natural pacemaker. There’s no ...
Atrioventricular nodal reentrant tachycardia (AVNRT) is a common supraventricular arrhythmia that arises due to a reentrant circuit located in or near the atrioventricular node. This condition ...
Your heart's job is to keep your pulse steady to pump blood throughout your body. Sometimes your heart rate is slower when you're relaxing, and sometimes it's faster when you're exercising or stressed ...
In patients with atrioventricular septal defect (AVSD), the occurrence of nonsurgical AV block has been reported. We have looked for an explanation in the development of the AV conduction system.
Atrioventricular reentrant tachycardia (AVRT) is a rhythm problem in your heart that makes it beat too fast. It results from an extra connection between your upper and lower chambers. You might hear ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
In this prospective, multicenter clinical trial, we randomly assigned patients with symptomatic, drug-resistant atrial fibrillation, an ejection fraction of 40% or less, and New York Heart Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results